HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
about
CCR5 monoclonal antibodies for HIV-1 therapyStoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.Chemokine receptor oligomerization and allostery.Viral exploitation and subversion of the immune system through chemokine mimicry.Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells.Peptide interactions with G-protein coupled receptors.Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.Heteromerization of human cytomegalovirus encoded chemokine receptors.Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cellsA novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry.Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates.Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination.Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPERBioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization.Modulation of chemokine receptor activity through dimerization and crosstalkPharmacological modulation of chemokine receptor function.Mechanisms regulating chemokine receptor activity.Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion.Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.Development of a rapid cell-fusion-based phenotypic HIV-1 tropism assayBlocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration.Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women.Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion.Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus.Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication.Regulation of CCR7-dependent cell migration through CCR7 homodimer formation.Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responses.Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens.Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins.Closely related, yet unique: Distinct homo- and heterodimerization patterns of G protein coupled chemokine receptors and their fine-tuning by cholesterol.
P2860
Q22242739-F92B21EA-1A1E-4B2D-976D-9FF94C2C35C3Q30447936-ECA684A4-9368-44F7-8CA3-505678AD525BQ30857101-A2A992D9-3DF8-4FAE-9C26-EED4A0FEFADCQ33810517-33862310-DD0C-4EBD-881C-ECDF7A1EA476Q33933260-7987CA7D-FE8E-4F99-AE19-E5B05B72791DQ34017536-DFB97151-FB40-4D81-B940-8956731BCC7AQ34483031-AEA1A23E-0130-43AD-8908-58140A990F4BQ34658462-6721B90E-EB40-4F22-BD1A-4A4CF0562A9AQ35167034-5CA5BBD3-29D8-4395-9766-5EDE76B80841Q35205365-EF1F1F0A-2639-41E2-B528-F28B7AB3CDE8Q35842577-6BBAABE3-EE56-4637-B597-2111D4DCF54CQ36334029-2D7991BD-35A3-4B5E-90E5-DE14DB9E3779Q36382002-8BF5C73E-F359-4CFB-B00A-D3F1C44E5624Q36597497-17187DDA-AF51-413B-A2C8-B56B7259D7B4Q36800401-B1327B53-6516-4433-A8BD-47C5D6CB8409Q37134357-57D92760-1906-4834-839F-5239975EDE99Q37355817-5BAA5105-27C4-47BE-B051-1CB4027A1221Q37893687-12AE4382-F28E-41B3-870B-2E1757033F13Q37942973-62F51C29-CCFF-465B-8FFA-E05DF1DE9003Q38309472-BAC7A25D-A769-4EC6-9CA7-FCA609D9938AQ38859512-7F36EFBE-1CAF-4CB7-834C-B01AE92556BEQ39094162-730EACF0-CE0A-44BA-846A-379CA30678EDQ39315677-94641FCE-738A-4C3F-90E6-F3A2A97B6A7BQ39556857-F873854E-9651-40F4-A8A9-8167DF2824E3Q39577265-7B0E5F32-2A68-4C6F-BF17-7233C7C3A00EQ39682931-AE54584C-1444-4BE1-88B6-F4179BE5FF55Q39684660-C35B4949-33D5-45BD-8AAD-F655CAF72520Q39717911-5216E792-A5E3-4554-8F88-8C929705AEB9Q41448192-8CB95ACA-E1DF-43E6-AF9E-525C6BD627A6Q42046489-6DD5EDC3-F1B4-4284-B07B-CF6BA0BA0407Q42817463-9E42BD9E-3549-44A2-9433-89AD75708991Q43112410-6A447DC3-35D7-4111-98F8-4A004863B13CQ43780931-BCEE0492-6220-4061-A443-8BD9A9BFFA92Q52660783-66B0C638-B94A-4E51-8C35-E909D7E0CD05
P2860
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
@ast
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
@en
type
label
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
@ast
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
@en
prefLabel
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
@ast
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.
@en
P2093
P2860
P1476
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
@en
P2093
Martín de Ana A
Martínez-A C
Rodríguez-Frade JM
Vila-Coro AJ
del Real G
P2860
P304
P356
10.1073/PNAS.050457797
10.1073/PNAS.97.7.3388
P407
P577
2000-03-01T00:00:00Z